cyclin d1 Search Results


  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86
    Santa Cruz Biotechnology cyclin d1
    Immunostaining for <t>cyclin</t> D1. A: Low-magnification view of embryonic mouse kidney at E21, showing positive <t>cyclin</t> D1 immunostaining in the immature cortical glomeruli. B: Higher power view showing that cyclin D1 is detected in vesicular-, comma-, and S-shaped bodies ( arrows ). In capillary loop glomeruli, positive staining in a nonpodocyte-specific distribution can be seen ( asterisks ). C: Cyclin D1 staining is not detected in the normal rat glomerulus.
    Cyclin D1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cyclin d1/product/Santa Cruz Biotechnology
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    cyclin d1 - by Bioz Stars, 2021-06
    86/100 stars
      Buy from Supplier

    99
    Cell Signaling Technology Inc cyclin d1
    Effects of downregulated miR-181a on the expression of tumorigenesis-associated proteins. (A) Western blot band of CDC25A, <t>cyclin</t> A2, p21 and <t>cyclin</t> D1 protein expression in each group of SGC-7901 cells. (B) Comparison of protein levels in each group of SGC-7901 cells. (C) Western blot band of Bcl-2 and Bax protein expression in each group of SGC-7901 cells. (D) Comparison of protein levels in each group of SGC-7901 cells. **P
    Cyclin D1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cyclin d1/product/Cell Signaling Technology Inc
    Average 99 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    cyclin d1 - by Bioz Stars, 2021-06
    99/100 stars
      Buy from Supplier

    99
    Abcam cyclin d1
    Effects of downregulated miR-181a on the expression of tumorigenesis-associated proteins. (A) Western blot band of CDC25A, <t>cyclin</t> A2, p21 and <t>cyclin</t> D1 protein expression in each group of SGC-7901 cells. (B) Comparison of protein levels in each group of SGC-7901 cells. (C) Western blot band of Bcl-2 and Bax protein expression in each group of SGC-7901 cells. (D) Comparison of protein levels in each group of SGC-7901 cells. **P
    Cyclin D1, supplied by Abcam, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cyclin d1/product/Abcam
    Average 99 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    cyclin d1 - by Bioz Stars, 2021-06
    99/100 stars
      Buy from Supplier

    N/A
    Recombinant protein of human cyclin D1 CCND1
      Buy from Supplier

    N/A
    This antibody recognizes a protein of 36kDa identified as Cyclin D1 It is a putative proto oncogene overexpressed in a wide variety of human neoplasms and a key cell cycle
      Buy from Supplier

    N/A
    Gene Silencers generally consist of pools of three to five target specific 19 25 nucleotide sequences in length For independent verification of cyclin D1 gene silencing results individual duplex components
      Buy from Supplier

    Image Search Results


    Immunostaining for cyclin D1. A: Low-magnification view of embryonic mouse kidney at E21, showing positive cyclin D1 immunostaining in the immature cortical glomeruli. B: Higher power view showing that cyclin D1 is detected in vesicular-, comma-, and S-shaped bodies ( arrows ). In capillary loop glomeruli, positive staining in a nonpodocyte-specific distribution can be seen ( asterisks ). C: Cyclin D1 staining is not detected in the normal rat glomerulus.

    Journal: The American Journal of Pathology

    Article Title: Differential Expression of D-Type Cyclins in Podocytes in Vitro and in Vivo

    doi:

    Figure Lengend Snippet: Immunostaining for cyclin D1. A: Low-magnification view of embryonic mouse kidney at E21, showing positive cyclin D1 immunostaining in the immature cortical glomeruli. B: Higher power view showing that cyclin D1 is detected in vesicular-, comma-, and S-shaped bodies ( arrows ). In capillary loop glomeruli, positive staining in a nonpodocyte-specific distribution can be seen ( asterisks ). C: Cyclin D1 staining is not detected in the normal rat glomerulus.

    Article Snippet: Indirect immunoperoxidase immunostaining was performed as previously reported using the following primary antibodies incubated overnight at 4°C: cyclin D1 (1:1000, mouse monoclonal, clone DCS-6; Oncogene, Boston, MA), cyclin D1 (1:600, mouse monoclonal, MS-210; Neomarkers, Fremont, CA), cyclin D1 (1:100, mouse monoclonal, clone A-12; Santa Cruz, Santa Cruz, CA), cyclin D3 (1:300, mouse monoclonal, clone DCS-22; Neomarkers), WT-1 (1:1200, rabbit polyclonal, clone C-19; Santa Cruz), Synaptopodin (1:50, gift of Dr. Peter Mundel, Departments of Medicine and Anatomy, Albert Einstein College, Bronx, NY) and Glepp1 (1:50; gift of Dr. Roger Wiggins, Department of Internal Medicine, University of Michigan, Ann Arbor, MI).

    Techniques: Immunostaining, Staining

    Detection of podocyte-specific proteins in cyclin D1−/− mice. Podocytes from adult cyclin D1−/− mice express WT-1 ( A ) and synaptopodin ( B ) markers of mature podocytes.

    Journal: The American Journal of Pathology

    Article Title: Differential Expression of D-Type Cyclins in Podocytes in Vitro and in Vivo

    doi:

    Figure Lengend Snippet: Detection of podocyte-specific proteins in cyclin D1−/− mice. Podocytes from adult cyclin D1−/− mice express WT-1 ( A ) and synaptopodin ( B ) markers of mature podocytes.

    Article Snippet: Indirect immunoperoxidase immunostaining was performed as previously reported using the following primary antibodies incubated overnight at 4°C: cyclin D1 (1:1000, mouse monoclonal, clone DCS-6; Oncogene, Boston, MA), cyclin D1 (1:600, mouse monoclonal, MS-210; Neomarkers, Fremont, CA), cyclin D1 (1:100, mouse monoclonal, clone A-12; Santa Cruz, Santa Cruz, CA), cyclin D3 (1:300, mouse monoclonal, clone DCS-22; Neomarkers), WT-1 (1:1200, rabbit polyclonal, clone C-19; Santa Cruz), Synaptopodin (1:50, gift of Dr. Peter Mundel, Departments of Medicine and Anatomy, Albert Einstein College, Bronx, NY) and Glepp1 (1:50; gift of Dr. Roger Wiggins, Department of Internal Medicine, University of Michigan, Ann Arbor, MI).

    Techniques: Mouse Assay

    Immunostaining for cyclins D1 and D3 in PHN rats and HIV-transgenic mice. A: Immunostaining for cyclin D1 was increased in PHN rats at day 5, and this was in a typical podocyte localization. B: Cyclin D1 staining increased in HIV-transgenic mice at 6 weeks. C: Cyclin D3 immunostaining was detected in podocytes of PHN rats at day 5, and was unchanged compared to normal. D: In HIV-transgenic mice, podocyte dedifferentiation and proliferation was associated with a decrease in cyclin D3 staining.

    Journal: The American Journal of Pathology

    Article Title: Differential Expression of D-Type Cyclins in Podocytes in Vitro and in Vivo

    doi:

    Figure Lengend Snippet: Immunostaining for cyclins D1 and D3 in PHN rats and HIV-transgenic mice. A: Immunostaining for cyclin D1 was increased in PHN rats at day 5, and this was in a typical podocyte localization. B: Cyclin D1 staining increased in HIV-transgenic mice at 6 weeks. C: Cyclin D3 immunostaining was detected in podocytes of PHN rats at day 5, and was unchanged compared to normal. D: In HIV-transgenic mice, podocyte dedifferentiation and proliferation was associated with a decrease in cyclin D3 staining.

    Article Snippet: Indirect immunoperoxidase immunostaining was performed as previously reported using the following primary antibodies incubated overnight at 4°C: cyclin D1 (1:1000, mouse monoclonal, clone DCS-6; Oncogene, Boston, MA), cyclin D1 (1:600, mouse monoclonal, MS-210; Neomarkers, Fremont, CA), cyclin D1 (1:100, mouse monoclonal, clone A-12; Santa Cruz, Santa Cruz, CA), cyclin D3 (1:300, mouse monoclonal, clone DCS-22; Neomarkers), WT-1 (1:1200, rabbit polyclonal, clone C-19; Santa Cruz), Synaptopodin (1:50, gift of Dr. Peter Mundel, Departments of Medicine and Anatomy, Albert Einstein College, Bronx, NY) and Glepp1 (1:50; gift of Dr. Roger Wiggins, Department of Internal Medicine, University of Michigan, Ann Arbor, MI).

    Techniques: Immunostaining, Transgenic Assay, Mouse Assay, Staining

    Specificity of Santa Cruz cyclin D1 antibody. Cyclin D−/− mice immunostained with the cyclin D1 antibody from Santa Cruz showed positive staining in a podocyte distribution. A: Low-power field; B: high-power field.

    Journal: The American Journal of Pathology

    Article Title: Differential Expression of D-Type Cyclins in Podocytes in Vitro and in Vivo

    doi:

    Figure Lengend Snippet: Specificity of Santa Cruz cyclin D1 antibody. Cyclin D−/− mice immunostained with the cyclin D1 antibody from Santa Cruz showed positive staining in a podocyte distribution. A: Low-power field; B: high-power field.

    Article Snippet: Indirect immunoperoxidase immunostaining was performed as previously reported using the following primary antibodies incubated overnight at 4°C: cyclin D1 (1:1000, mouse monoclonal, clone DCS-6; Oncogene, Boston, MA), cyclin D1 (1:600, mouse monoclonal, MS-210; Neomarkers, Fremont, CA), cyclin D1 (1:100, mouse monoclonal, clone A-12; Santa Cruz, Santa Cruz, CA), cyclin D3 (1:300, mouse monoclonal, clone DCS-22; Neomarkers), WT-1 (1:1200, rabbit polyclonal, clone C-19; Santa Cruz), Synaptopodin (1:50, gift of Dr. Peter Mundel, Departments of Medicine and Anatomy, Albert Einstein College, Bronx, NY) and Glepp1 (1:50; gift of Dr. Roger Wiggins, Department of Internal Medicine, University of Michigan, Ann Arbor, MI).

    Techniques: Mouse Assay, Staining

    A: Western blot analysis for cyclin D1 and cyclin D3 in conditionally immortalized podocytes in vitro . Cyclin D1 was abundant in proliferating podocytes grown under permissive conditions. The levels of cyclin D1 decreased when podocytes were grown under restrictive conditions, and this coincided with a decrease in proliferation, and the development of a differentiated phenotype. There was a progressive increase in cyclin D3 levels when grown under restrictive conditions, compared to permissive conditions. Tubulin was used to assure equal loading. b: Immunofluorescence for cyclin D1 and cyclin D3 in conditionally immortalized podocytes. Cyclin D1 stains positive in proliferating podocytes grown under permissive conditions ( b ), and is barely detected under growth restrictive conditions ( D ). Hoechst staining was used as a nuclear counterstain ( A and C ). Cyclin D3 staining was not detected in proliferating podocytes ( F ), but was abundant in quiescent and differentiated podocytes grown under growth restrictive conditions ( H ). Hoechst staining was used as a nuclear counterstain ( E , G ).

    Journal: The American Journal of Pathology

    Article Title: Differential Expression of D-Type Cyclins in Podocytes in Vitro and in Vivo

    doi:

    Figure Lengend Snippet: A: Western blot analysis for cyclin D1 and cyclin D3 in conditionally immortalized podocytes in vitro . Cyclin D1 was abundant in proliferating podocytes grown under permissive conditions. The levels of cyclin D1 decreased when podocytes were grown under restrictive conditions, and this coincided with a decrease in proliferation, and the development of a differentiated phenotype. There was a progressive increase in cyclin D3 levels when grown under restrictive conditions, compared to permissive conditions. Tubulin was used to assure equal loading. b: Immunofluorescence for cyclin D1 and cyclin D3 in conditionally immortalized podocytes. Cyclin D1 stains positive in proliferating podocytes grown under permissive conditions ( b ), and is barely detected under growth restrictive conditions ( D ). Hoechst staining was used as a nuclear counterstain ( A and C ). Cyclin D3 staining was not detected in proliferating podocytes ( F ), but was abundant in quiescent and differentiated podocytes grown under growth restrictive conditions ( H ). Hoechst staining was used as a nuclear counterstain ( E , G ).

    Article Snippet: Indirect immunoperoxidase immunostaining was performed as previously reported using the following primary antibodies incubated overnight at 4°C: cyclin D1 (1:1000, mouse monoclonal, clone DCS-6; Oncogene, Boston, MA), cyclin D1 (1:600, mouse monoclonal, MS-210; Neomarkers, Fremont, CA), cyclin D1 (1:100, mouse monoclonal, clone A-12; Santa Cruz, Santa Cruz, CA), cyclin D3 (1:300, mouse monoclonal, clone DCS-22; Neomarkers), WT-1 (1:1200, rabbit polyclonal, clone C-19; Santa Cruz), Synaptopodin (1:50, gift of Dr. Peter Mundel, Departments of Medicine and Anatomy, Albert Einstein College, Bronx, NY) and Glepp1 (1:50; gift of Dr. Roger Wiggins, Department of Internal Medicine, University of Michigan, Ann Arbor, MI).

    Techniques: Western Blot, In Vitro, Immunofluorescence, Staining

    Effects of downregulated miR-181a on the expression of tumorigenesis-associated proteins. (A) Western blot band of CDC25A, cyclin A2, p21 and cyclin D1 protein expression in each group of SGC-7901 cells. (B) Comparison of protein levels in each group of SGC-7901 cells. (C) Western blot band of Bcl-2 and Bax protein expression in each group of SGC-7901 cells. (D) Comparison of protein levels in each group of SGC-7901 cells. **P

    Journal: Oncology Reports

    Article Title: MicroRNA-181a promotes cell proliferation and inhibits apoptosis in gastric cancer by targeting RASSF1A

    doi: 10.3892/or.2018.6632

    Figure Lengend Snippet: Effects of downregulated miR-181a on the expression of tumorigenesis-associated proteins. (A) Western blot band of CDC25A, cyclin A2, p21 and cyclin D1 protein expression in each group of SGC-7901 cells. (B) Comparison of protein levels in each group of SGC-7901 cells. (C) Western blot band of Bcl-2 and Bax protein expression in each group of SGC-7901 cells. (D) Comparison of protein levels in each group of SGC-7901 cells. **P

    Article Snippet: Anti-cyclin A2 (mouse IgG; cat. no. 4656) and cyclin D1 (rabbit IgG; cat. no. 2922) were purchased from Cell Signaling Technology, Inc. (Danvers, MA, USA).

    Techniques: Expressing, Western Blot

    Effects of upregulated miR-181a on the expression of tumorigenesis-associated proteins. (A) Western blot band of CDC25A, cyclin A2, p21 and cyclin D1 protein expression in each group of AGS cells. (B) Comparison of protein levels in each group of AGS cells. (C) Western blot band of Bcl-2 and Bax protein expression in each group of AGS cells. (D) Comparison of protein levels in each group of AGS cells. **P

    Journal: Oncology Reports

    Article Title: MicroRNA-181a promotes cell proliferation and inhibits apoptosis in gastric cancer by targeting RASSF1A

    doi: 10.3892/or.2018.6632

    Figure Lengend Snippet: Effects of upregulated miR-181a on the expression of tumorigenesis-associated proteins. (A) Western blot band of CDC25A, cyclin A2, p21 and cyclin D1 protein expression in each group of AGS cells. (B) Comparison of protein levels in each group of AGS cells. (C) Western blot band of Bcl-2 and Bax protein expression in each group of AGS cells. (D) Comparison of protein levels in each group of AGS cells. **P

    Article Snippet: Anti-cyclin A2 (mouse IgG; cat. no. 4656) and cyclin D1 (rabbit IgG; cat. no. 2922) were purchased from Cell Signaling Technology, Inc. (Danvers, MA, USA).

    Techniques: Expressing, Western Blot

    USP14 inhibition or silencing blocks G 0 /G 1 to S phase transition in breast cancer cells. a Fluorescence-activated cell sorting analysis (FACS) was performed on the indicated breast cancer cells exposed to IU1 for 48 h. ( n = 3). b The percentage of cells in each population was calculated. Mean ± S.D. ( n = 3). c FACS analysis was performed on the indicated breast cancer cells that stably expressed USP14 shRNA or control shRNA for 48 h. The percentage of cells in each population was calculated. Mean ± S.D. ( n = 3). d Protein lysates were collected from the indicated breast cancer cells treated with IU1 for 48 h. Western blot assay was used to detect CDK4, CDK2, and cyclin D1 protein expression. GAPDH was used as an internal control. e Protein lysates were collected from the indicated breast cancer cells stably expressing USP14 shRNA or control shRNA. Western blot assay was used to detect CDK4, CDK2, and cyclin D1 expression. GAPDH was used as an internal control

    Journal: Oncogene

    Article Title: Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination

    doi: 10.1038/s41388-017-0069-z

    Figure Lengend Snippet: USP14 inhibition or silencing blocks G 0 /G 1 to S phase transition in breast cancer cells. a Fluorescence-activated cell sorting analysis (FACS) was performed on the indicated breast cancer cells exposed to IU1 for 48 h. ( n = 3). b The percentage of cells in each population was calculated. Mean ± S.D. ( n = 3). c FACS analysis was performed on the indicated breast cancer cells that stably expressed USP14 shRNA or control shRNA for 48 h. The percentage of cells in each population was calculated. Mean ± S.D. ( n = 3). d Protein lysates were collected from the indicated breast cancer cells treated with IU1 for 48 h. Western blot assay was used to detect CDK4, CDK2, and cyclin D1 protein expression. GAPDH was used as an internal control. e Protein lysates were collected from the indicated breast cancer cells stably expressing USP14 shRNA or control shRNA. Western blot assay was used to detect CDK4, CDK2, and cyclin D1 expression. GAPDH was used as an internal control

    Article Snippet: Antibodies were from the following corporations: anti-GAPDH (MB001), anti-CDK2 (BS1050), anti-GFP (BSAP0675M), anti-Bcl-2 (BS70205) (Bioworld Technology, Inc., Louis Park, MN, USA); anti-Ubiquitin (catalog no. 3936), anti-PARP (9532), anti-CDK4 (12790), anti-USP14 (11931), anti-Lamin B (13435), anti-HSP90 (4877), HA-tag (3724), anti-K48-ub (12805), anti-cyclin D1 (2922) (Cell Signaling Technology, Beverly, MA, USA); anti-AR (ab108341), anti-UCHL5 (ab124931) (Abcam, USA).

    Techniques: Inhibition, Sublimation, Fluorescence, FACS, Stable Transfection, shRNA, Western Blot, Expressing